Athenex to exit drug compounding business and axe 92 employees at NY plant
The New York-based cancer biotech Athenex has faced some struggles over the past year, but the company is moving to shutter the doors of one …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
